Guidance document: Product Monograph (2020)
The purpose of this guidance document is to assist sponsors in developing product monographs with acceptable format and content. Health Canada reviews the product monograph as part of the drug review process, as it forms an integral part of a new drug submission. A product monograph is intended to provide the necessary information for the safe and effective use of a new drug and also to serve as a standard against which all promotion and advertising of the drug can be compared.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Guidance document: Product Monograph (2020)HTMLEnglish publication HTML
-
Guidance document: Product Monograph (2020)HTMLFrench publication HTML
Similar records